182 related articles for article (PubMed ID: 23607596)
1. Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.
Chen D; Wang W; Qin JJ; Wang MH; Murugesan S; Nadkarni DH; Velu SE; Wang H; Zhang R
Curr Cancer Drug Targets; 2013 Jul; 13(6):651-60. PubMed ID: 23607596
[TBL] [Abstract][Full Text] [Related]
2. A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action.
Wang W; Rayburn ER; Velu SE; Chen D; Nadkarni DH; Murugesan S; Chen D; Zhang R
Breast Cancer Res Treat; 2010 Sep; 123(2):321-31. PubMed ID: 19936915
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo anticancer activity of novel synthetic makaluvamine analogues.
Wang W; Rayburn ER; Velu SE; Nadkarni DH; Murugesan S; Zhang R
Clin Cancer Res; 2009 May; 15(10):3511-8. PubMed ID: 19451594
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacology of BA-TPQ, a novel synthetic iminoquinone anticancer agent.
Ezell SJ; Li H; Xu H; Zhang X; Gurpinar E; Zhang X; Rayburn ER; Sommers CI; Yang X; Velu SE; Wang W; Zhang R
Mar Drugs; 2010 Jul; 8(7):2129-41. PubMed ID: 20714427
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of anticancer efficacy and pharmacological properties of FBA-TPQ, a novel synthetic makaluvamine analog.
Zhang X; Xu H; Zhang X; Voruganti S; Murugesan S; Nadkarni DH; Velu SE; Wang MH; Wang W; Zhang R
Mar Drugs; 2012 May; 10(5):1138-1155. PubMed ID: 22822362
[TBL] [Abstract][Full Text] [Related]
6. The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation.
Lee SA; Jung M
J Biol Chem; 2007 May; 282(20):15271-83. PubMed ID: 17371872
[TBL] [Abstract][Full Text] [Related]
7. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells.
Li Y; Zhao L; Sun H; Yu J; Li N; Liang J; Wang Y; He M; Bai X; Yu Z; Zheng Z; Mi X; Wang E; Wei M
PLoS One; 2012; 7(8):e44254. PubMed ID: 22952942
[TBL] [Abstract][Full Text] [Related]
8. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
[TBL] [Abstract][Full Text] [Related]
9. Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression.
Fu CY; Chen MC; Tseng YS; Chen MC; Zhou Z; Yang JJ; Lin YM; Viswanadha VP; Wang G; Huang CY
Environ Toxicol; 2019 Aug; 34(8):902-911. PubMed ID: 31044527
[TBL] [Abstract][Full Text] [Related]
10. Ziyuglycoside II induces cell cycle arrest and apoptosis through activation of ROS/JNK pathway in human breast cancer cells.
Zhu X; Wang K; Zhang K; Zhu L; Zhou F
Toxicol Lett; 2014 May; 227(1):65-73. PubMed ID: 24680927
[TBL] [Abstract][Full Text] [Related]
11. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα.
Vethakanraj HS; Sesurajan BP; Padmanaban VP; Jayaprakasam M; Murali S; Sekar AK
Anticancer Drugs; 2018 Jan; 29(1):50-60. PubMed ID: 29023248
[TBL] [Abstract][Full Text] [Related]
13. MEKK1-MKK4-JNK-AP1 pathway negatively regulates Rgs4 expression in colonic smooth muscle cells.
Zhang Y; Li F; Liu S; Wang H; Mahavadi S; Murthy KS; Khalili K; Hu W
PLoS One; 2012; 7(4):e35646. PubMed ID: 22545125
[TBL] [Abstract][Full Text] [Related]
14. Mixed lineage kinase ZAK utilizing MKK7 and not MKK4 to activate the c-Jun N-terminal kinase and playing a role in the cell arrest.
Yang JJ
Biochem Biophys Res Commun; 2002 Sep; 297(1):105-10. PubMed ID: 12220515
[TBL] [Abstract][Full Text] [Related]
15. The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway.
Li Z; Lim SK; Liang X; Lim YP
J Biol Chem; 2018 Dec; 293(52):20014-20028. PubMed ID: 30442712
[TBL] [Abstract][Full Text] [Related]
16. Vitexin 6, a novel lignan, induces autophagy and apoptosis by activating the Jun N-terminal kinase pathway.
Zhou J; Hu H; Long J; Wan F; Li L; Zhang S; Shi YE; Chen Y
Anticancer Drugs; 2013 Oct; 24(9):928-36. PubMed ID: 23965728
[TBL] [Abstract][Full Text] [Related]
17. Highly efficient delivery of potent anticancer iminoquinone derivative by multilayer hydrogel cubes.
Xue B; Wang W; Qin JJ; Nijampatnam B; Murugesan S; Kozlovskaya V; Zhang R; Velu SE; Kharlampieva E
Acta Biomater; 2017 Aug; 58():386-398. PubMed ID: 28583901
[TBL] [Abstract][Full Text] [Related]
18. Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cells.
Rabi T; Banerjee S
Mol Carcinog; 2008 Jun; 47(6):415-23. PubMed ID: 18058803
[TBL] [Abstract][Full Text] [Related]
19. Curcumin induced human gastric cancer BGC-823 cells apoptosis by ROS-mediated ASK1-MKK4-JNK stress signaling pathway.
Liang T; Zhang X; Xue W; Zhao S; Zhang X; Pei J
Int J Mol Sci; 2014 Sep; 15(9):15754-65. PubMed ID: 25198898
[TBL] [Abstract][Full Text] [Related]
20. Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.
Chen T; Xu Y; Guo H; Liu Y; Hu P; Yang X; Li X; Ge S; Velu SE; Nadkarni DH; Wang W; Zhang R; Wang H
PLoS One; 2011; 6(6):e20729. PubMed ID: 21673964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
